Current research associates SETD1A dysfunction with neurodevelopmental disorders (NDDs), early onset epilepsy, and schizophrenia (SCZ; Singh et al., 2016; Yu et al., 2019; Kummeling et al., 2020). Here, SETD1A is linked to epilepsy.